ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.
Dr. Dax. Kurbegov invites physician invesigators to the the meeting to engage in discussion of best practices and develop solutions to challenges affecting the cancer research community.
At the Plenary Session of this year’s ASCO Annual Meeting, the results of a longitudinal trial begun in 2007 showed me that patient engagement is much more important that I had imagined.
As president this year, I have had the opportunity to observe firsthand the many things ASCO does to make a difference in cancer care WITH YOU, and I cannot wait to share them over the next few days.
Dr. Julia Close invites women attending the ASCO Annual Meeting to be a part of conversations about gender in medicine at the Women's Networking Center, either by joining for planned session or simply by stopping by to meet colleagues and have a cup of coffee.
The new Education Council will ensure that ASCO’s educational goals and strategies match its programs, and will evaluate collaboration across ASCO’s education portfolio.
Get the most out of your experience at the ASCO Annual Meeting by making preparations and familiarizing yourself with the program and materials before you arrive in Chicago.
During our national meetings, when we describe cases with CT scans and labs, why don’t we take the next step and inivite patients to tell their stories in their own words?
BBCC5 offered didactic sessions with presentations on recent advances in breast cancer research and management and 1-hour tumor board sessions where a panel of experts and the audience discuss real cases of patients with breast cancer.
In your quest to find healing words for your patients, Dr. Wendy S. Harpham encourages you to attend Saturday's General Session 4: “One of Our Own—Insights of Health Care Providers on Coping with Cancer,” at the 2017 Cancer Survivorship Symposium.
The inaugural ASCO-SITC Clinical Immuno-Oncology Symposium will have three networking sessions, designed to help physicians determine how immunotherapy best fits into their practice, and to explore career development for newcomers to the field of immunotherapy.
A highly interactive and personal panel discussion and Q&A session will take place in the evening on January 26, before the official opening of the Cancer Survivorship Symposium in San Diego, CA.
Attend the 2017 Cancer Survivorship Symposium's Presidents Panel to hear Drs. Wanda Filer, Nitin Damle, and Julie M. Vose discuss how professional societies are workingto meet the needs of their members with respect to the care of cancer survivors.
This new meeting will focus on the clinical application of immunology to cancer care, including immune checkpoint inhibitor therapy and novel combinations, the use of adoptive T-cell therapy and CAR T-cells, predictive and prognostic biomarkers, and more.
ASCO provides answers to some of the most frequently asked questions about the Society's proposed pathway for Maintenance of Certification, in response to your insightful feedback.
Dr. Smita Bhatia reflects on Dr. Anna T. Meadows' achievements and contributions to the field of survivorship as the 2017 Cancer Survivorship Symposium approaches.
The National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Annual Meeting took place on October 17-18. Here are some highlights on a selection of many of the topics and interactions over that meeting.
The ASCO MOC alternate pathway proposal shifts the focus of the recertification process to continuous learning in oncology. As this plan is meant to address your needs, the proposal is presented for your input.
Blogs
ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.
No Results.
Pages
Advertisement